Please login to the form below

Not currently logged in
Email:
Password:

product launch

This page shows the latest product launch news and features for those working in and with pharma, biotech and healthcare.

Novartis buys CellforCure to bolster cell, gene therapy

Novartis buys CellforCure to bolster cell, gene therapy

have plagued the product since its US launch last year. ... It has reportedly been struggling with variability in product specifications that in some cases have led to manufacturing failures.

Latest news

More from news
Approximately 1 fully matching, plus 202 partially matching documents found.

Latest Intelligence

  • Innovation in merger control and the impact on the pharmaceutical sector Innovation in merger control and the impact on the pharmaceutical sector

    Surely in the launch of potential new products. But future new products (or products in an advanced-stage of development) were not a focus of Dow/DuPont. ... In contrast, between the moment new molecules are discovered and the point that firms can launch

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    One potential major product launch for 2019 will be novel pain drug tanezumab. ... Our pricing philosophy is to price to the value of the product and price inside a competitive marketplace.

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Alnylam's Theresa Heggie. Alnylam and its extraordinary ‘gene silencing’ technology is making its debut in Europe with the launch of Onpattro. ... Going it alone. That means a lot is riding on the early success of Onpattro in the US and Europe, and

  • KAM 2.0 KAM 2.0

    We recently worked on a programme with a global top 15 pharmaceutical company with a vast product portfolio and an imminent, crucial product launch. ... With the relationship and goodwill established, and clear tangible outcomes after the initial meeting,

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    The firm currently has a market capitalisation value of $8.9bn, even before its first product launch. ... can be measured by increasing vector copy number (VCN) in the drug product.

More from intelligence
Approximately 0 fully matching, plus 30 partially matching documents found.

Latest appointments

  • Mereo BioPharma appoints head of patient access and commercial planning Mereo BioPharma appoints head of patient access and commercial planning

    Hughes-Wilson brings in-depth market access and product launch expertise as well as a proven ability to develop and lead commercial planning efforts globally. ... In this role, Hughes-Wilson was responsible for Sobi’s commercialisation approach and

  • Alacrita appoints Anna Casse as MD Alacrita appoints Anna Casse as MD

    for Alacrita Europe and help build its European Launch platform. ... I am looking forward to driving further growth in the areas of product launch and commercialisation, and ensuring that our US clients have access to a European launch platform that is

  • Hanover Health bolsters PR leadership team Hanover Health bolsters PR leadership team

    Davies moves to Hanover Health from Tonic Life Communications where he was a senior account director specialising in oncology and neurology product communications, having first joined as an account director in ... 2011. She brings experience in pre- and

  • Dr Andrew Webber joins Life Healthcare Communications Dr Andrew Webber joins Life Healthcare Communications

    In his new in-house role, Dr Webber will be responsible for overseeing the global launch of a new product within the agency's service portfolio.

  • Former Boehringer diabetes marketing VP joins Gelesis Former Boehringer diabetes marketing VP joins Gelesis

    Dr Pass brings over 20 years of commercial expertise in the diabetes and metabolics areas among others to Gelesis, and takes on responsibility for all business development and product commercialisation, including ... Yishai Zohar, chief executive officer

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

  • Shionogi Ltd. appoints Star for UK launch

    sales resource to facilitate the launch of a women’s health product in the UK. ... We are excited to be the partner of choice from the early phase of the UK operation and will provide the high-quality individuals desired to ensure a successful product

  • New ICMJE Guidelines and their Impact on Biotech

    Because of this focus, they simply don’t have the infrastructure in place that we typically associate with implementing a medical communications plan to support a future product launch. ... crucial to securing the funding needed to initiate the pivotal

  • Using technology to make your exhibitions stand more successful

    Among other things, they can help you to generate leads (during and long after the tradeshow is finished), raise brand awareness, network, and support a product launch.  In fact, according to ... And, through creative exhibition stands, product launches

  • Trending: using social media to understand your pharma market

    In a recent project, we conducted social listening for a product that was about to be launched. ... We worked closely with the brand managers to apply the insights to brand planning, this helped us shape the messaging of the launch strategy.

  • Biotech: it's a people business

    By developing a team of people who specialise and focus on the product, a company can nurture it along – often a small, novel or complex drug needs that in the beginning. .

More from PMHub
Approximately 6 fully matching, plus 38 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics